Medtronic Evolut™ TAVR System Achieves Impressive Five-Year Outcomes in Low-Risk Aortic Stenosis Patients Medtronic's Evolut™ TAVR system demonstrates outstanding performance and long-term safety for low-risk patients with aortic stenosis over five years, offering a promising alternative to surgery.

Medtronic Evolut™ TAVR System Achieves Impressive Five-Year Outcomes in Low-Risk Aortic Stenosis Patients #Ireland #Aortic_Stenosis #Galway #Medtronic_TAVR #cardiovascular_outcomes